In the present study, our aim was to assess in septic cancer patients the concentrations of a widely used biomarker of infection, CRP, comparing the baseline concentrations and response to antibiotic therapy in those with and without neutropenia. The gene discussed is CRP; the disease is Decreased total neutrophil count.